"A monumental milestone" in the battle against malaria was set Monday with the rollout of the R21/Matrix-M vaccine in the West African nation of Cote d'Ivoire.
Co-developed by the University of Oxford and Serum Institute of India, the vaccine is set immunize around 6.6M children in 15 African nations over 2024-25.